Vertex/CRISPR Prepare To Take Exa-Cel To Regulators For SCD, TDT

 
• By Alaric DeArment
  
Vertex and CRISPR plan to start a rolling submission of exa-cel, previously CTX001, in SCD and TDT in November • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies